Millions of American suffer from some form of osteoporosis or bone disease. Fosamax, a product of Merck, is one of the most popular medications used to treat and prevent bone loss. This bisphosphonate was first introduced in 1995 and was designed to improve bone density and decrease bone breaks and fractures that are related to bone resorption. While many patients have benefited from taking this medication, others have noted serious side effects and complications, such as weakened bones and chronic pain.
How Fosamax Works
Fosamax, commonly known as Alendronate, is typically prescribed for postmenopausal women, men with osteoporosis, and patients who suffer from Paget’s disease. The bisphosphonate within the medication helps to inhibit bone resorption by binding to the hydroxyapatite in the bone. As a result, patients may notice a gradual decline in bone loss and counteract the negative effects of certain corticosteroid medications that often contribute to bone resorption.
Fosamax has been associated with a number of side effects and complications that patients should be aware of, including:
Patients should seek the aid of a trained medical professional if any serious reactions occur while taking this medication. The medication has also been linked to bone fractures. The FDA ordered Fosamax and other similar drugs to add warning labels regarding the increased likelihood of thighbone fractures for patients using bisphosphonate medications in 2010. In 2011, they went on to require that Fosamax add a statement to their warning label which indicates that the drug does not have an optimal duration for use.
Individuals who have taken Fosamax and experienced any serious side effects may be eligible for compensation. Speaking with a legal professional can provide patients with the information and guidance they need to receive the benefits to which they are entitled.